Although the Authority has experienced a very low influx of applications for registration of veterinary medicinal products to date, the few received were processed within TATs. In addition, the Veterinary Medicines Unit has successfully conducted a listing exercise for the VMPs that have been on the market before its inception to ensure sustainable access and control or regulation of VMPs on the market.
The List has been presented before the Registration Committee and is set to be presented before the Board in January 2022. The list will be published on the BoMRA website as soon as it is approved. Furthermore, the Unit has managed to document 90% (target 90%) of the identified processes. Unfortunately like any other Unit, the Veterinary Medicines Unit lost its two (2) Dossier Assessment Specialists who left the employ of BoMRA.
The Botswana Medicines Regulatory Authority (BoMRA) Was established through the Medicines and Related Substances Act of 2013. The MRSA Authorises BoMRA to perform functions given by the shareholder – The Government of Botswana. The MRSA of 2013 replaced the repealed Drugs and Related Substances Act No.
Designed And Developed By Ntebogang Technologies